Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
Nanobiotechnology is considered to be one of the fastest emerging fields. It is still a relatively new and exciting area of research with considerable potential for development. Among the inorganic nanomaterials, biogenically synthesized silver nanoparticles (bio-AgNPs) have been frequently used due...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5617665ed8674b8a9186793ef8d230af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5617665ed8674b8a9186793ef8d230af |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5617665ed8674b8a9186793ef8d230af2021-11-25T18:30:43ZBiogenic Silver Nanoparticles: What We Know and What Do We Need to Know?10.3390/nano111129012079-4991https://doaj.org/article/5617665ed8674b8a9186793ef8d230af2021-10-01T00:00:00Zhttps://www.mdpi.com/2079-4991/11/11/2901https://doaj.org/toc/2079-4991Nanobiotechnology is considered to be one of the fastest emerging fields. It is still a relatively new and exciting area of research with considerable potential for development. Among the inorganic nanomaterials, biogenically synthesized silver nanoparticles (bio-AgNPs) have been frequently used due to their unique physicochemical properties that result not only from their shape and size but also from surface coatings of natural origin. These properties determine antibacterial, antifungal, antiprotozoal, anticancer, anti-inflammatory, and many more activities of bio-AgNPs. This review provides the current state of knowledge on the methods and mechanisms of biogenic synthesis of silver nanoparticles as well as their potential applications in different fields such as medicine, food, agriculture, and industries.Mahendra RaiAvinash P. IngleJoanna Trzcińska-WencelMagdalena WypijShital BondeAlka YadavGabriela KratošováPatrycja GolińskaMDPI AGarticlesilver nanoparticlesbiosynthesisapplicationbiodistributiontoxicityChemistryQD1-999ENNanomaterials, Vol 11, Iss 2901, p 2901 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
silver nanoparticles biosynthesis application biodistribution toxicity Chemistry QD1-999 |
spellingShingle |
silver nanoparticles biosynthesis application biodistribution toxicity Chemistry QD1-999 Mahendra Rai Avinash P. Ingle Joanna Trzcińska-Wencel Magdalena Wypij Shital Bonde Alka Yadav Gabriela Kratošová Patrycja Golińska Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know? |
description |
Nanobiotechnology is considered to be one of the fastest emerging fields. It is still a relatively new and exciting area of research with considerable potential for development. Among the inorganic nanomaterials, biogenically synthesized silver nanoparticles (bio-AgNPs) have been frequently used due to their unique physicochemical properties that result not only from their shape and size but also from surface coatings of natural origin. These properties determine antibacterial, antifungal, antiprotozoal, anticancer, anti-inflammatory, and many more activities of bio-AgNPs. This review provides the current state of knowledge on the methods and mechanisms of biogenic synthesis of silver nanoparticles as well as their potential applications in different fields such as medicine, food, agriculture, and industries. |
format |
article |
author |
Mahendra Rai Avinash P. Ingle Joanna Trzcińska-Wencel Magdalena Wypij Shital Bonde Alka Yadav Gabriela Kratošová Patrycja Golińska |
author_facet |
Mahendra Rai Avinash P. Ingle Joanna Trzcińska-Wencel Magdalena Wypij Shital Bonde Alka Yadav Gabriela Kratošová Patrycja Golińska |
author_sort |
Mahendra Rai |
title |
Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know? |
title_short |
Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know? |
title_full |
Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know? |
title_fullStr |
Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know? |
title_full_unstemmed |
Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know? |
title_sort |
biogenic silver nanoparticles: what we know and what do we need to know? |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/5617665ed8674b8a9186793ef8d230af |
work_keys_str_mv |
AT mahendrarai biogenicsilvernanoparticleswhatweknowandwhatdoweneedtoknow AT avinashpingle biogenicsilvernanoparticleswhatweknowandwhatdoweneedtoknow AT joannatrzcinskawencel biogenicsilvernanoparticleswhatweknowandwhatdoweneedtoknow AT magdalenawypij biogenicsilvernanoparticleswhatweknowandwhatdoweneedtoknow AT shitalbonde biogenicsilvernanoparticleswhatweknowandwhatdoweneedtoknow AT alkayadav biogenicsilvernanoparticleswhatweknowandwhatdoweneedtoknow AT gabrielakratosova biogenicsilvernanoparticleswhatweknowandwhatdoweneedtoknow AT patrycjagolinska biogenicsilvernanoparticleswhatweknowandwhatdoweneedtoknow |
_version_ |
1718411074710011904 |